Tailored osmotic delivery of nifedipine: a formulation and evaluation approach

Authors

  • K.Vinod Kumar Professor, SIMS college of Pharmacy, Guntur
  • B.Thangabalan Principal, SIMS college of Pharmacy, Guntur
  • Sheerla. Dinakar Reddy SIMS college of Pharmacy, Guntur

DOI:

https://doi.org/10.47957/ijpda.v12i4.610

Keywords:

Nifedipine, antianginal, antihypertensive, drug delivery system

Abstract

Nifedipine is used as an antianginal (especially in Prinzmetal's angina) and antihypertensive. The mechanism by which nifedipine reduces arterial blood pressure involves peripheral arterial vasodilatation and consequently a reduction in peripheral vascular resistance. The primary objective of controlled drug delivery system is to ensure safety and to improve the patient compliance as well as efficacy of the drugs and this can be achieved by less frequent dosing and better control of drug plasma level.

Downloads

Download data is not yet available.

References

Rajan k. verma et al., Osmotic Pumps in Drug Delivery of critical reviews in therapeutic drug delivery systems Year 2004, Volume 21 / Issue 6.

2. Longer M.A., Robinson J.R. "Sustained release drug delivery system" chapter 91 in "Remington's pharmaceutical sciences" 18th edition, Mack Publishing Company 1990: 1675-1684pp.

Lordi N.G. "Sustained release dosage form" chapter 14 in "Theory and practice of Industrial Pharmacy" edited by Lachman et al., 3rd edition, Varghese Publishing House, 1991: 430-431pp.

Welling P.G., Dobrinska M.R. "Dosing considerations and bioavailability assessment of controlled drug delivery systems" chapter 6 in "Controlled drug delivery; fundamentals and applications" edited by Robinson J.R., Vincent Lee, 2nd edition, Marcel Dekker Inc., Volume 29, 1978: 254-289pp.

Kumar S., Sharma, "Controlled Release Dosage Forms" The Eastern Pharmacist, 2001: Sept.: 17-21pp.

Hui ho-wah, "Design and fabrication of oral controlled release drug delivery systems" chapter 9 in "Controlled drug delivery; fundamentals and applications", edited by Robinson J.R., Vincent Lee, 2nd edition, Marcel Dekker Inc., Volume 29, 1978: 391-420pp.

Verma,R.K., Garg,S.,Pharm.Technol.,2001, 25, 1.

Theuwes, F., Swanson, D. R., Guitttard, G., Ayer, A., Br. J.Clin. Pharmacology, (1985), 19, 69-76.

Santus, G., Baker, R.W., J. Control. Release, 1995, 35, 1-21.

Verma, R.K., Garg, S., J. Control. Release, 2002, 79, 7-27.

Verma,R.K., Mishra, B., Drug Dev. Ind .Pharm. 2001, 22.

Santus, G., Baker, R.W., J.Control.Release, 1995, 35, 2.

Pfefer,W.E.P.Osmotishe Umtersuchen, Leipzig,1877.

Ramakrishna., Mishra B. Pharmazie 2001; 56: 958.

Bhatt P Padmanabh. Osmotic drug delivery system for poorly soluble drug, Pharma venture ltd. (2004).

Published

2024-12-31
Statistics
179 Views | 101 Downloads
Citatons

How to Cite

K, V. K., T. B, and D. R. Sheerla. “Tailored Osmotic Delivery of Nifedipine: A Formulation and Evaluation Approach”. International Journal of Pharmaceutics and Drug Analysis, vol. 12, no. 4, Dec. 2024, pp. 6-13, doi:10.47957/ijpda.v12i4.610.

Issue

Section

Research Articles
Share |